Wolfgang Albrecht
Chief Executive Officer at HepaRegeniX GmbH
Profile
Wolfgang Albrecht is the founder of HepaRegeniX GmbH, a company founded in 2017.
He currently holds the position of Co-Chief Operating Officer & Managing Director at HepaRegeniX GmbH.
Dr. Albrecht's current job is as a Financial Analyst at Landesbank Baden-Württemberg (Broker), a position he has held since 1985.
He has also worked as an Analyst at Bankgesellschaft Berlin AG (Berlin Branch).
Wolfgang Albrecht active positions
| Companies | Position | Start |
|---|---|---|
Landesbank Baden-Württemberg (Broker)
 Landesbank Baden-Württemberg (Broker) Investment Banks/BrokersFinance Landesbank Baden-Württemberg (Broker) (LBBW-Broker) is the brokerage division of Landesbank Baden-Württemberg in Germany. Headquartered in Stuttgart, the firm was founded in 1999 and provides capital market services to medium-sized companies, listed groups, institutional customers, savings banks and retail customers. | Analyst-Equity | - |
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Chief Executive Officer | 01/01/2017 |
Former positions of Wolfgang Albrecht
| Companies | Position | End |
|---|---|---|
| Bankgesellschaft Berlin AG (Berlin Branch) | Analyst-Equity | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Landesbank Baden-Württemberg (Broker)
Landesbank Baden-Württemberg (Broker) Investment Banks/BrokersFinance Landesbank Baden-Württemberg (Broker) (LBBW-Broker) is the brokerage division of Landesbank Baden-Württemberg in Germany. Headquartered in Stuttgart, the firm was founded in 1999 and provides capital market services to medium-sized companies, listed groups, institutional customers, savings banks and retail customers. | Finance |
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Commercial Services |
| Bankgesellschaft Berlin AG (Berlin Branch) | Finance |
- Stock Market
- Insiders
- Wolfgang Albrecht
